Literature DB >> 10481088

nalB-type mutations causing the overexpression of the MexAB-OprM efflux pump are located in the mexR gene of the Pseudomonas aeruginosa chromosome.

K Saito1, H Yoneyama, T Nakae.   

Abstract

Two mutations, one at the nalB and the other at the mexR locus, in the Pseudomonas aeruginosa chromosome are known to cause overexpression of the MexAB-OprM efflux pump. Based on the following results, we concluded that nalB is the mutation that has occurred within the mexR gene of the P. aeruginosa chromosome. (i) Nucleotide sequencing of the mex operon upstream region of 21 independent nalB-type mutants including the original nalB9 revealed that all the mutations were located within the mexR gene. The mutations were classified into three different groups and nine types including single base substitutions, single base deletions and base insertions. (ii) Substitution of the mutant mexR with the wild-type mexR and replacement of the wild-type mexR with a defined mexR mutation resulted in the expression of wild-type and nalB-type MexAB-OprM respectively, which was confirmed by testing the antibiotic susceptibility and beta-galactosidase activity of the mexA-lacZ translational fusion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10481088     DOI: 10.1111/j.1574-6968.1999.tb08709.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  39 in total

1.  Two efflux systems expressed simultaneously in multidrug-resistant Pseudomonas aeruginosa.

Authors:  L Pumbwe; L J Piddock
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

Review 2.  Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria.

Authors:  K Poole
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

3.  FarR regulates the farAB-encoded efflux pump of Neisseria gonorrhoeae via an MtrR regulatory mechanism.

Authors:  E-H Lee; C Rouquette-Loughlin; J P Folster; W M Shafer
Journal:  J Bacteriol       Date:  2003-12       Impact factor: 3.490

4.  Mutations affecting DNA-binding activity of the MexR repressor of mexR-mexA-mexB-oprM operon expression.

Authors:  Kohjiro Saito; Hiroyuki Akama; Eisaku Yoshihara; Taiji Nakae
Journal:  J Bacteriol       Date:  2003-10       Impact factor: 3.490

5.  The mexR repressor of the mexAB-oprM multidrug efflux operon in Pseudomonas aeruginosa: characterization of mutations compromising activity.

Authors:  Lateef Adewoye; Ainsley Sutherland; Ramakrishnan Srikumar; Keith Poole
Journal:  J Bacteriol       Date:  2002-08       Impact factor: 3.490

6.  Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously.

Authors:  Catherine Llanes; Didier Hocquet; Christelle Vogne; Dounia Benali-Baitich; Catherine Neuwirth; Patrick Plésiat
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

7.  nalD encodes a second repressor of the mexAB-oprM multidrug efflux operon of Pseudomonas aeruginosa.

Authors:  Yuji Morita; Lily Cao; Virginia C Gould; Matthew B Avison; Keith Poole
Journal:  J Bacteriol       Date:  2006-10-06       Impact factor: 3.490

8.  Protein modulator of multidrug efflux gene expression in Pseudomonas aeruginosa.

Authors:  Denis M Daigle; Lily Cao; Sebastien Fraud; Mark S Wilke; Angela Pacey; Rachael Klinoski; Natalie C Strynadka; Charles R Dean; Keith Poole
Journal:  J Bacteriol       Date:  2007-06-01       Impact factor: 3.490

9.  The crystal structure of MexR from Pseudomonas aeruginosa in complex with its antirepressor ArmR.

Authors:  Mark S Wilke; Markus Heller; A Louise Creagh; Charles A Haynes; Lawrence P McIntosh; Keith Poole; Natalie C J Strynadka
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-23       Impact factor: 11.205

10.  Macrolide antibiotic-mediated downregulation of MexAB-OprM efflux pump expression in Pseudomonas aeruginosa.

Authors:  Makoto Sugimura; Hideaki Maseda; Hideaki Hanaki; Taiji Nakae
Journal:  Antimicrob Agents Chemother       Date:  2008-08-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.